Skip to main content
. 2025 Aug 6;17(15):2582. doi: 10.3390/cancers17152582
CRC Colorectal Cancer
MSI-H Microsatellite Instability-High
dMMR Deficient Mismatch Repair
BCG Bacillus Calmette–Guérin
FDA Food and Drug Administration
TAA Tumor-Associated Antigen
TSA Tumor-Specific Antigen
CTL Cytotoxic T Lymphocyte
DC Dendritic Cell
GMP Good Manufacturing Practice
GVAX GM-CSF-secreting Allogeneic Tumor Cell Vaccine
GM-CSF Granulocyte–Macrophage Colony-Stimulating Factor
DFS Disease-Free Survival
mRNA Messenger Ribonucleic Acid
shRNA Short Hairpin RNA
DNA Deoxyribonucleic Acid
ICI Immune Checkpoint Inhibitor
TME Tumor Microenvironment
MSS Microsatellite Stable
pMMR Proficient Mismatch Repair
MRD Minimal Residual Disease
KRAS Kirsten Rat Sarcoma Viral Oncogene Homolog
CTC Circulating Tumor Cell
PD-L1 Programmed Death-Ligand 1
iPSC Induced Pluripotent Stem Cell
hESC Human Embryonic Stem Cells
CD4+ Cluster of Differentiation 4 Positive (T Cell)
CD8+ Cluster of Differentiation 8 Positive (T Cell)
HNRNPU Heterogeneous Nuclear Ribonucleoprotein U
NCL Nucleolin
CD40L CD40 ligand
Th1 Type 1 T Helper Cell
HER Human Epidermal Growth Factor Receptor 2
Treg Regulatory T Cell
MDSC Myeloid-Derived Suppressor Cell
HLA Human Leukocyte Antigen
VEGFR Vascular Endothelial Growth Factor Receptor
CEA Carcinoembryonic Antigen